Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Purine nucleoside metabolism encompasses the interconnected biochemical pathways responsible for the synthesis, salvage, and degradation of purine nucleotides (AMP and GMP). These pathways are critical for maintaining cellular nucleotide pools essential for DNA/RNA synthesis, energy transfer, signal transduction, and other vital cellular functions. Key enzymes and regulatory mechanisms tightly control these processes, and dysregulation can lead to various diseases, including gout, Lesch-Nyhan syndrome, and cancer. Drugs targeting these pathways are used as immunosuppressants, anti-cancer agents and to treat hyperuricemia.
Varies depending on the specific enzyme or step targeted. Examples include xanthine oxidase inhibition (allopurinol), IMPDH inhibition (mycophenolate mofetil), inhibition of de novo purine synthesis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purine Nucleoside Metabolism.